Largest phase 3 trial of novel treatment for hypertension shows promising results
Meeting Announcement
Lorundrostat, a novel therapy which blocks the production of aldosterone from the adrenal glands, demonstrated clinically meaningful and sustained reductions in blood pressure in 1,083 patients with uncontrolled or resistant hypertension, according to the results of a phase 3 trial announced today.
During REM sleep, the body enters a state of paralysis. This can pose a danger for patients with weakened diaphragms due to neuromuscular diseases. Now new research published at the ATS 2025 International Conference has shown that antidepressants that suppress REM sleep are associated with improved survival in people with amyotrophic lateral sclerosis (ALS).
The Labour History Research Unit at Anglia Ruskin University (ARU) in England is hosting the first ever conference to focus on the record to date of Sir Keir Starmer’s government. The public event, called Starmer: Year One, is taking place at Anglia Ruskin’s Cambridge campus on Saturday, 14 June.